|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of goods sold | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| General and administrative | |||||
| Sales and marketing | |||||
| Research and development | |||||
| Foreign exchange impact of lease liabilities and forward contracts | |||||
| Total operating expenses | |||||
| Operating income | |||||
| Other expenses: | |||||
| Interest expense, net | |||||
| Change in fair value of compound net derivative liability | |||||
| Loss on extinguishment of debt | |||||
| Total other expenses | |||||
| Income (loss) before income tax expense | |||||
| Income tax expense | |||||
| Net income (loss) | |||||
| Basic net income (loss) per share (in Dollars per share) | |||||
| Diluted net income (loss) per share (in Dollars per share) | |||||
| Weighted average number of shares outstanding: | |||||
| Basic (in Shares) | |||||
| Diluted (in Shares) |
Loading...